PL2015767T3 - Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego - Google Patents

Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego

Info

Publication number
PL2015767T3
PL2015767T3 PL07748079T PL07748079T PL2015767T3 PL 2015767 T3 PL2015767 T3 PL 2015767T3 PL 07748079 T PL07748079 T PL 07748079T PL 07748079 T PL07748079 T PL 07748079T PL 2015767 T3 PL2015767 T3 PL 2015767T3
Authority
PL
Poland
Prior art keywords
antisecretory factor
intraocular hypertension
treating intraocular
treating
hypertension
Prior art date
Application number
PL07748079T
Other languages
English (en)
Polish (pl)
Inventor
Hans-Arne Hansson
Stefan Lange
Eva Jennische
Original Assignee
Lantmaennen As Faktor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantmaennen As Faktor Ab filed Critical Lantmaennen As Faktor Ab
Publication of PL2015767T3 publication Critical patent/PL2015767T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL07748079T 2006-04-27 2007-04-27 Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego PL2015767T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0600932 2006-04-27
PCT/SE2007/000414 WO2007126364A2 (en) 2006-04-27 2007-04-27 Use of antisecretory factors for treating intraocular hypertension
EP07748079.6A EP2015767B1 (en) 2006-04-27 2007-04-27 Use of antisecretory factor for treating intraocular hypertension

Publications (1)

Publication Number Publication Date
PL2015767T3 true PL2015767T3 (pl) 2016-05-31

Family

ID=38561776

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07748079T PL2015767T3 (pl) 2006-04-27 2007-04-27 Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
PL12157100T PL2468292T3 (pl) 2006-04-27 2007-04-27 Nowe peptydy wykazujące działanie przeciwwydzielnicze

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL12157100T PL2468292T3 (pl) 2006-04-27 2007-04-27 Nowe peptydy wykazujące działanie przeciwwydzielnicze

Country Status (18)

Country Link
US (2) US8207296B2 (https=)
EP (2) EP2468292B8 (https=)
JP (2) JP5284948B2 (https=)
KR (1) KR20090040404A (https=)
CN (2) CN102633863B (https=)
AU (1) AU2007244004B2 (https=)
BR (1) BRPI0710959B8 (https=)
CA (2) CA2771087C (https=)
DK (2) DK2468292T3 (https=)
ES (2) ES2773945T3 (https=)
IL (1) IL194773A (https=)
MX (1) MX2008013769A (https=)
NZ (2) NZ572255A (https=)
PL (2) PL2015767T3 (https=)
RU (1) RU2458703C2 (https=)
SG (1) SG171602A1 (https=)
WO (1) WO2007126364A2 (https=)
ZA (1) ZA200809115B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2015767T3 (pl) * 2006-04-27 2016-05-31 Lantmaennen As Faktor Ab Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
US9962424B2 (en) 2007-04-27 2018-05-08 Lantmännen As-Faktor Ab Use of antisecretory factors (AF) for optimizing cellular uptake
EP2396024A4 (en) * 2009-02-11 2013-02-27 Lantmaennen As Faktor Ab USE OF ANTISECRREATORY FACTORS (AF) FOR OPTIMIZATION OF CELLULAR ABSORPTION
WO2013050795A1 (en) * 2011-10-03 2013-04-11 Femtonics Kft. Use of photoactive compounds
CA3036216A1 (en) * 2012-12-20 2014-06-26 Lantmannen As-Faktor Ab Use of antisecretory factor (af) in glioblastoma treatment
CN107949392B (zh) * 2015-07-10 2022-10-11 兰特门内阿斯-法克托尔公司 用于生产含高含量af-16的蛋黄的方法
JP6999638B2 (ja) 2016-07-18 2022-01-18 ラントメネン・メディカル・アーベー 抗分泌性因子１７
CA3103164A1 (en) 2018-06-28 2020-01-02 Lantmannen Medical Ab Antisecretory factor for use in treatment and/or prevention of acute respiratory failure
WO2020065091A1 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted wheat
WO2020065089A2 (en) 2018-09-28 2020-04-02 Lantmännen Functional Foods Ab A consumable product comprising malted dehulled oat
CN115605214A (zh) 2020-03-26 2023-01-13 兰特门内保健食品公司（Se） 用于促进身体活动恢复的包含麦芽化谷物的可消耗产品
US20240148709A1 (en) * 2022-11-08 2024-05-09 Aisa Pharma, Inc. Methods of treating eye pain and eye disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH682716A5 (de) 1992-01-13 1993-11-15 Christian Fricker Benzo-Pyrone und/oder Dobesilat-Calcium enthaltende pharmazeutische Zusammensetzung.
US5585401A (en) * 1994-12-09 1996-12-17 The Reents Of The University Of California Method for enhancing outflow of aqueous humor in treatment of glaucoma
SE508609C2 (sv) * 1995-08-24 1998-10-19 Rural Patent Svenska Ab Antisekretorisk faktor - dess aminosyrasekvens, nubleinsyrasekvens och användning
AU732508B2 (en) * 1996-01-26 2001-04-26 Governing Council Of The University Of Toronto, The Nucleic acids and proteins related to Alzheimer's disease, and uses therefor
SE9604251L (sv) 1996-11-20 1997-12-22 Svenska Lantmaennen Riksfoerbu Födoämne som vid förtäring inducerar antisekretoriska proteiner
SE513496C2 (sv) * 1998-12-17 2000-09-18 Rural Patent Svenska Ab NASP-berikad äggula samt dess användning
CN1335887A (zh) * 1999-06-21 2002-02-13 印坎药物股份有限公司 血管抑制素∶一种Cys－Ser－Val－Thr－Cys－Gly特异性肿瘤细胞粘附受体
RU2192898C1 (ru) * 2001-08-16 2002-11-20 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ лечения герпетического кератита с изъязвлением
GB0322645D0 (en) 2003-09-26 2003-10-29 Melacure Therapeutics Ab Use of antisecretory factor peptides
MX2008013777A (es) * 2006-04-27 2009-02-03 Lantmaennen As Faktor Ab Usos medicos adicionales de la proteina antisecretora.
PL2015767T3 (pl) * 2006-04-27 2016-05-31 Lantmaennen As Faktor Ab Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
BRPI0710858A2 (pt) * 2006-04-27 2011-05-17 Lantmonnen As Faktor Ab uso de uma proteìna anti-secretora, um derivado, homólogo e/ou fragmento da mesma, tendo atividade anti-secretora, e/ou um sal farmaceuticamente ativo da mesma

Also Published As

Publication number Publication date
AU2007244004B2 (en) 2012-02-09
PL2468292T3 (pl) 2020-08-24
IL194773A0 (en) 2011-08-01
ES2561945T3 (es) 2016-03-01
CA2771087C (en) 2016-03-15
RU2458703C2 (ru) 2012-08-20
CA2650344A1 (en) 2007-11-08
WO2007126364A8 (en) 2009-07-23
IL194773A (en) 2015-07-30
ES2773945T3 (es) 2020-07-15
NZ598426A (en) 2012-08-31
RU2008146733A (ru) 2010-06-10
BRPI0710959A2 (pt) 2012-02-28
EP2468292A1 (en) 2012-06-27
EP2468292B8 (en) 2020-02-26
KR20090040404A (ko) 2009-04-24
US8207296B2 (en) 2012-06-26
BRPI0710959B8 (pt) 2021-05-25
BRPI0710959B1 (pt) 2018-11-06
DK2015767T3 (en) 2016-02-08
JP5284948B2 (ja) 2013-09-11
JP2012153695A (ja) 2012-08-16
EP2015767A2 (en) 2009-01-21
WO2007126364A2 (en) 2007-11-08
CA2650344C (en) 2017-10-31
EP2015767B1 (en) 2016-01-06
SG171602A1 (en) 2011-06-29
WO2007126364A3 (en) 2008-03-06
JP2009535329A (ja) 2009-10-01
CN101432013B (zh) 2015-01-07
CN102633863A (zh) 2012-08-15
CA2771087A1 (en) 2007-11-08
NZ572255A (en) 2012-03-30
AU2007244004A1 (en) 2007-11-08
US20090162296A1 (en) 2009-06-25
MX2008013769A (es) 2009-02-03
US20120283191A1 (en) 2012-11-08
CN101432013A (zh) 2009-05-13
CN102633863B (zh) 2014-08-06
DK2468292T3 (da) 2020-03-23
ZA200809115B (en) 2009-07-29
US9000125B2 (en) 2015-04-07
EP2468292B1 (en) 2019-12-18

Similar Documents

Publication Publication Date Title
PL2015767T3 (pl) Zastosowanie czynnika przeciwwydzielniczego do leczenia nadciśnienia śródgałkowego
IL198851A0 (en) Methods for treating hypercholesterolemia
ZA200903233B (en) Quinazolines for PDK1 inhibition
ZA200808307B (en) Quinazolines for PDK1 inhibition
ZA200810105B (en) Means for controlling the progression of myopia
IL193451A0 (en) Surgical devices for treating pelvic conditions
EP2051725A4 (en) METHOD FOR THE TREATMENT OF GRAIN WITH SATURATION FACTORS
IL197914A (en) Antibodies to ereg for cancer treatment
EP1993539A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
ZA200903533B (en) Process for the preparation of rosuvastatin
PL2101777T3 (pl) Kompozycja do leczenia nadciśnienia płucnego
GB2446944B (en) Removal of prosthesis
IL198005A0 (en) Ccr2 antagonists for treatment of fibrosis
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
GB0624977D0 (en) Artificial candle
EP2013404A4 (en) OPERATING PROCESS FOR DRYERS
IL198941A0 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
EP1940397A4 (en) METHOD FOR TREATING HYPERTONIA
EP1993536A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
EP1993537A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES
GB0609402D0 (en) Prosthesis
EP1996191A4 (en) THIAZOLONE AS A PI3 KINASE INHIBITOR
EP2003971A4 (en) RNAI-mediated inhibition of status in association with the histamine receptor H1
ZA200807615B (en) Renin inhibitors for the treatment of hypertension
EP1993538A4 (en) THIAZOLONES AS INHIBITORS OF P13-KINASES